このアイテムのアクセス数: 85

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
circj.CJ-20-0681.pdf6.03 MBAdobe PDF見る/開く
タイトル: Long-Term Impact of Diabetes Mellitus on Initially Conservatively Managed Patients With Severe Aortic Stenosis
著者: Song, Xiaoyang
Saito, Naritatsu
Morimoto, Takeshi
Taniguchi, Tomohiko
Shiomi, Hiroki  kyouindb  KAKEN_id
Ando, Kenji
Nagao, Kazuya
Kanamori, Norio
Murata, Koichiro
Kitai, Takeshi
Kawase, Yuichi
Izumi, Chisato
Miyake, Makoto
Mitsuoka, Hirokazu
Kato, Masashi
Hirano, Yutaka
Matsuda, Shintaro
Inada, Tsukasa
Murakami, Tomoyuki
Takeuchi, Yasuyo
Yamane, Keiichiro
Toyofuku, Mamoru
Ishii, Mitsuru
Minamino-Muta, Eri
Kato, Takao  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-8213-7999 (unconfirmed)
Yoshikawa, Yusuke
Inoko, Moriaki
Ikeda, Tomoyuki
Ishii, Katsuhisa
Hotta, Kozo
Higashitani, Nobuya
Kato, Yoshihiro
Inuzuka, Yasutaka
Maeda, Chiyo
Jinnai, Toshikazu
Morikami, Yuko
Minatoya, Kenji
Kimura, Takeshi
著者名の別形: 齋藤, 成達
塩見, 紘樹
松田, 真太郎
牟田, 恵理
加藤, 貴雄
芳川, 裕亮
湊谷, 謙司
木村, 剛
キーワード: Aortic stenosis
Diabetes mellitus
Survival analysis
発行日: 25-Jun-2021
出版者: Japanese Circulation Society
誌名: Circulation Journal
巻: 85
号: 7
開始ページ: 1083
終了ページ: 1092
抄録: BACKGROUND: Although diabetes mellitus (DM) is a common comorbidity of aortic stenosis (AS), clinical evidence about the long-term effect of DM on patients with AS is insufficient.Methods and Results:Data were acquired from CURRENT AS, a large Japanese multicenter registry that enrolled 3, 815 patients with severe AS. Patients without initial valve replacement were defined as the conservative group; among them, 621 (23.4%) had DM, whereas 1997 did not. The DM group was further divided into 2 groups according to insulin treatment (insulin-treated DM, n=130; non-insulin treated DM, n=491). The primary outcome was a composite of aortic valve (AV)-related death and heart failure (HF) hospitalization. Secondary outcomes were AV-related death, HF hospitalization, all-cause death, cardiovascular death, sudden death, and surgical or transcatheter AV replacement during follow up. As a result, DM was associated with higher risk for the primary outcome (52.8% vs. 42.9%, P<0.001), with a statistically significant adjusted hazard ratio (HR 1.33, 95% confidence interval: 1.14-1.56, P<0.001). All secondary outcomes were not significantly different between DM and non-DM patients after adjusting for confounding factors, except for HF hospitalization. Insulin use was not associated with higher incidence of primary or secondary outcome. CONCLUSIONS: In initially conservatively managed patients with AS, DM was independently associated with higher risk for a composite of AV-related death or HF hospitalization; however, insulin use was not associated with poor outcomes.
著作権等: © 2021, THE JAPANESE CIRCULATION SOCIETY
This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
URI: http://hdl.handle.net/2433/276998
DOI(出版社版): 10.1253/circj.CJ-20-0681
PubMed ID: 33208572
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons